Monamine-depleting properties of a new and very potent enzyme-activated irreversible inhibitor of aromatic aminoacid decarboxylase: alpha-monofluoromethyldopa [proceedings]. 1979

M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka

UI MeSH Term Description Entries
D008297 Male Males
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001679 Biogenic Amines A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology. Amines, Biogenic,Biogenic Amine,Amine, Biogenic
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D065105 Aromatic Amino Acid Decarboxylase Inhibitors Compounds and drugs that block or inhibit the enzymatic action of AROMATIC AMINO ACID DECARBOXYLASES. Pharmaceutical agents in this category are used in conjunction with LEVODOPA in order to slow its metabolism. Aromatic-L-Amino-Acid Decarboxylase Inhibitors,DOPA Decarboxylase Inhibitors,Dihydroxyphenylalanine Decarboxylase Inhibitors,Aromatic L Amino Acid Decarboxylase Inhibitors,Decarboxylase Inhibitors, Aromatic-L-Amino-Acid,Decarboxylase Inhibitors, DOPA,Decarboxylase Inhibitors, Dihydroxyphenylalanine,Inhibitors, Aromatic-L-Amino-Acid Decarboxylase,Inhibitors, DOPA Decarboxylase,Inhibitors, Dihydroxyphenylalanine Decarboxylase

Related Publications

M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka
January 1980, Journal of cardiovascular pharmacology,
M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka
November 1979, British journal of pharmacology,
M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka
November 1984, Cancer research,
M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka
May 1981, Biochemistry,
M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka
September 1989, Preventive medicine,
M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka
July 1979, British journal of pharmacology,
M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka
December 1983, The Journal of biological chemistry,
M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka
September 1978, Cancer research,
M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka
January 1980, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry,
M J Jung, and M G Palfreyman, and G Ribereau-Gayon, and J Wagner, and M Zraïka
February 1979, Life sciences,
Copied contents to your clipboard!